Cencora, Inc.
Explore Cencora
Core profile pages, annual revenue records, and related research hubs for this company.
Acquisitions
4
Total Acquisitions
$13.9B
Disclosed Deal Value
2025
$4.4B
Acquire a majority interest in a retina-specialty management services organization.
Broadened Cencora's specialty provider-services relationships in ophthalmology.
The 2025 Form 10-K describes the RCA acquisition as part of Cencora's specialty growth priorities.
2021
$6.5B
Expand international pharmaceutical distribution and healthcare services.
Strengthened Cencora's European and international footprint.
Alliance Healthcare became a major component of international healthcare solutions.
2015
$2.5B
Expand animal health distribution and services.
Added scale in veterinary distribution and broadened Cencora's healthcare distribution platform.
Animal health became a complementary business alongside human pharmaceutical distribution.
2012
$520M
Add global specialty transportation and logistics capabilities for biopharmaceutical customers.
Expanded Cencora's ability to serve clinical trial, specialty, and temperature-sensitive logistics needs.
World Courier became an important part of Cencora's global commercialization and logistics platform.
Cencora's strategy is to protect core U.S. distribution scale while expanding specialty, international healthcare solutions, biopharma commercialization, cold-chain logistics, and services that are more valuable to manufacturers and providers than basic wholesale movement.
Cencora makes money primarily through high-volume pharmaceutical wholesale distribution. It also earns revenue from specialty distribution, provider services, international distribution, biopharma logistics, commercialization services, and animal-health distribution.
Cencora uses deals to deepen specialty and global distribution capabilities.
Deals often add specialty logistics or international adjacency.
M&A reinforces distribution and specialty leadership.
This Cencora acquisitions page summarizes notable transactions and strategic investments.